69 results on '"A. Vaporciyan"'
Search Results
2. Financial Toxicity in Patients With Resected Lung Cancer
3. Financial Toxicity in Patients With Resected Lung Cancer
4. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed
5. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for whom Surgery Should Not Be Delayed
6. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival
7. Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non–Small-Cell Lung Cancer Data Set
8. Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery
9. Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization
10. Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer
11. Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer
12. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell‐free DNA by next‐generation sequencing
13. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas MD Anderson Cancer Center experience
14. Gamification in thoracic surgical education: Using competition to fuel performance
15. 23 The role of pneumonectomy after neoadjuvant chemotherapy for N2 non–small cell lung cancer
16. Telomere Length and Recurrence Risk after Curative Resection in Patients with Early-Stage Non–Small-Cell Lung Cancer: A Prospective Cohort Study
17. Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus
18. Sternal metastasis of renal cell carcinoma: The role of metastasectomy
19. Apples and oranges: Understanding what our trainees need
20. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory
21. Cardiothoracic surgery residency training: Past, present, and future
22. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort
23. Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy
24. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy
25. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer
26. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis
27. Who will determine the educational needs of our trainees?
28. Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy
29. POSTOPERATIVE COMPLICATIONS AFTER RADICAL NEPHRECTOMY WITH IVC THROMBECTOMY EXPERIENCE WITH 265 CONSECUTIVE PATIENTS FROM A SINGLE CENTER: 2006
30. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins
31. Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals
32. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study
33. Combined Modality Therapy of cT2N0M0 Esophageal Cancer
34. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy
35. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction
36. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients
37. Complete lung parenchyma–sparing resection of the right main stem bronchus and bronchus intermedius
38. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy
39. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma
40. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era
41. Superior sulcus tumors with vertebral body involvement: A multimodality approach
42. Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents
43. Esophageal tumor length is independently associated with long-term survival
44. Adenocarcinoma of the lower esophagus with Barrettʼs esophagus or without Barrettʼs esophagus: differences in patientsʼ survival after preoperative chemoradiation
45. Comment on “Treatment of Non-small Cell Lung Cancer Stage IIIA: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)”
46. 3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer (NSCLC)
47. Cardiac Autotransplantation for Malignant or Complex Primary Left-Heart Tumors
48. Prognostic Significance of Ataxia-Telangiectasia Mutated, Dna-Dependent Protein Kinase Catalytic Subunit, and Ku Heterodimeric Regulatory Complex 86-Kd Subunit Expression in Patients With Nonsmall Cell Lung Cancer
49. Isolated Lung Perfusion, Is it Time to Deal With the 800 Pound Gorilla?
50. Comparison of Limited Surgery and Three-Dimensional Conformal Radiation in High-Risk Patients with Stage I Non-small Cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.